Bionano Genomics (BNGO) Total Debt (2017 - 2023)

Bionano Genomics (BNGO) has 7 years of Total Debt data on file, last reported at $10.0 million in Q3 2023.

• For the quarter ending Q3 2023, Total Debt rose 7.49% year-over-year to $10.0 million; the trailing twelve-month figure through Sep 2023 stood at $10.0 million (up 7.49% YoY), and the FY2022 full-year result was $9.4 million, changed N/A from the prior year.
• Total Debt held at $10.0 million in Q3 2023, from $10.0 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $40.2 million in Q4 2019 to a low of $9.2 million in Q2 2022.
• A 5-year average of $16.8 million and a median of $15.7 million in 2020 frame the typical range for Total Debt.
• Across the five-year window, Total Debt jumped 344.88% in 2019 and tumbled 59.36% in 2020, its largest moves.
• Tracing BNGO's Total Debt over 5 years: stood at $40.2 million in 2019, then plunged by 59.36% to $16.3 million in 2020, then dropped by 8.94% to $14.9 million in 2021, then tumbled by 36.89% to $9.4 million in 2022, then climbed by 6.59% to $10.0 million in 2023.
• Business Quant data shows BNGO's Total Debt at $10.0 million in Q3 2023, $10.0 million in Q2 2023, and $9.5 million in Q1 2023.